Unknown

Dataset Information

0

Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations.


ABSTRACT: Binding selectivity is a requirement for the development of a safe drug, and it is a critical property for chemical probes used in preclinical target validation. Engineering selectivity adds considerable complexity to the rational design of new drugs, as it involves the optimization of multiple binding affinities. Computationally, the prediction of binding selectivity is a challenge, and generally applicable methodologies are still not available to the computational and medicinal chemistry communities. Absolute binding free energy calculations based on alchemical pathways provide a rigorous framework for affinity predictions and could thus offer a general approach to the problem. We evaluated the performance of free energy calculations based on molecular dynamics for the prediction of selectivity by estimating the affinity profile of three bromodomain inhibitors across multiple bromodomain families, and by comparing the results to isothermal titration calorimetry data. Two case studies were considered. In the first one, the affinities of two similar ligands for seven bromodomains were calculated and returned excellent agreement with experiment (mean unsigned error of 0.81 kcal/mol and Pearson correlation of 0.75). In this test case, we also show how the preferred binding orientation of a ligand for different proteins can be estimated via free energy calculations. In the second case, the affinities of a broad-spectrum inhibitor for 22 bromodomains were calculated and returned a more modest accuracy (mean unsigned error of 1.76 kcal/mol and Pearson correlation of 0.48); however, the reparametrization of a sulfonamide moiety improved the agreement with experiment.

SUBMITTER: Aldeghi M 

PROVIDER: S-EPMC5253712 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations.

Aldeghi Matteo M   Heifetz Alexander A   Bodkin Michael J MJ   Knapp Stefan S   Biggin Philip C PC  

Journal of the American Chemical Society 20170109 2


Binding selectivity is a requirement for the development of a safe drug, and it is a critical property for chemical probes used in preclinical target validation. Engineering selectivity adds considerable complexity to the rational design of new drugs, as it involves the optimization of multiple binding affinities. Computationally, the prediction of binding selectivity is a challenge, and generally applicable methodologies are still not available to the computational and medicinal chemistry commu  ...[more]

Similar Datasets

| S-EPMC3557591 | biostudies-literature
| S-EPMC10308817 | biostudies-literature
| S-EPMC3157700 | biostudies-literature
| S-EPMC2868600 | biostudies-literature
| S-EPMC7806944 | biostudies-literature
| S-EPMC3285237 | biostudies-literature
| S-EPMC4127432 | biostudies-literature
| S-EPMC5825213 | biostudies-literature
| S-EPMC5869689 | biostudies-literature
| S-EPMC4442669 | biostudies-literature